Gain TherapeuticsGANX
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 38 institutions reported holding Gain Therapeutics Inc. (GANX) in their 13F filings, up 3 from Q2 2025. 9 opened new positions and 6 sold out. The largest holders were Jones Financial Companies LLLP ($1.2M), Greenlight Capital (DME Capital Management) ($1.0M) and Vanguard Group Inc. ($946K). 3 famous investors held it, including David Einhorn (0.0% of Greenlight Capital (DME Capital Management)'s portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Gain Therapeutics Inc.
- CUSIP
- 36269B105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $494K |
| Exits | 6 | $5.5M |
All 13F filers, Q2 2025 → Q3 2025: 981,026 shares bought and 427,223 shares sold, net +553,803 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 38 holders
| Jones Financial Companies LLLP | 0.00% | Reduce -0.0% | 676,822 | $1.2M |
| Greenlight Capital (DME Capital Management) | 0.04% | No change | 566,130 | $1.0M |
| Vanguard Group Inc. | 0.00% | No change | 534,352 | $946K |
| Citadel Advisors | 0.00% | Add +130.8% | 373,558 | $661K |
| Geode Capital Management, LLC | 0.00% | Add +18.5% | 344,146 | $609K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Add +77.5% | 318,645 | $564K |
| Marshall Wace, LLP | 0.00% | Reduce -36.6% | 175,107 | $310K |
| Morgan Stanley | 0.00% | Add +103.5% | 155,675 | $276K |
| UBS Group AG | 0.00% | Add +331.1% | 140,677 | $249K |
| Renaissance Technologies | 0.00% | Add +34.1% | 126,100 | $223K |
| BlackRock, Inc. | 0.00% | Add +3.3% | 116,184 | $206K |
| State Street Corp. | 0.00% | Add +28.1% | 91,137 | $161K |
| Northern Trust Corp. | 0.00% | Reduce -11.8% | 88,399 | $156K |
| Susquehanna International Group, LLP | 0.00% | Add +1.1% | 80,435 | $142K |
| Jane Street Group, LLC | 0.00% | New | 72,450 | $128K |
| Virtu Financial LLC | 0.01% | Add +126.9% | 54,008 | $96K |
| XTX Topco Ltd | 0.01% | New | 54,202 | $96K |
| NorthCoast Asset Management LLC | 0.00% | No change | 47,578 | $84K |
| Squarepoint Ops LLC | 0.00% | New | 38,537 | $68K |
| Prelude Capital Management, LLC | 0.01% | No change | 35,820 | $63K |
| Benedict Financial Advisors Inc. | 0.01% | Add +55.6% | 35,000 | $62K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 30,004 | $53K |
| Two Sigma Securities, LLC | 0.01% | New | 27,323 | $48K |
| JPMorgan Chase & Co. | 0.00% | New | 26,280 | $47K |
| HRT Financial LP | 0.00% | New | 19,717 | $34K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | New | 15,556 | $31K |
| Group One Trading LLC | 0.00% | Add +162.1% | 16,775 | $30K |
| Sandhill Capital Partners LLC | 0.00% | No change | 15,400 | $27K |
| Kestra Advisory Services, LLC | 0.00% | New | 12,000 | $21K |
| HighTower Advisors, LLC | 0.00% | New | 11,574 | $20K |
| Bison Wealth, LLC | 0.00% | No change | 10,750 | $20K |
| NewEdge Advisors, LLC | 0.00% | No change | 10,600 | $19K |
| Creekmur Asset Management LLC | 0.00% | No change | 4,440 | $8K |
| MAI Capital Management | 0.00% | No change | 4,410 | $8K |
| Bank of America Corp. | 0.00% | Reduce -6.2% | 3,907 | $7K |
| Arax Advisory Partners | 0.00% | Add +30.0% | 3,250 | $6K |
| Wells Fargo & Company | 0.00% | No change | 2,650 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +118.4% | 2,064 | $4K |
"% of holder's portfolio" is GANX's weight in each manager's 13F, not the share of Gain Therapeutics Inc. the manager owns.